Cabaletta Bio
CABA · NASDAQ
$1.61+$0.13 (+8.78%)TodayMarket closed ·
Prev close $1.48
EPS: actual vs estimate
Beat the estimate in 4 of the last 8 quarters, by 9.7% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.3807 | -$0.34 | +10.7% |
| Q1 FY26 | -$0.4095 | -$0.39 | +4.8% |
| Q4 FY25 | -$0.4702 | -$0.40 | +14.9% |
| Q3 FY25 | -$0.4814 | -$0.44 | +8.6% |
| Q2 FY25 | -$0.6627 | -$0.73 | −10.2% |
| Q1 FY25 | -$0.6675 | -$0.71 | −6.4% |
| Q4 FY24 | -$0.6434 | -$0.65 | −1.0% |
| Q3 FY24 | -$0.6081 | -$0.62 | −2.0% |
Earnings calls
- Morgan Stanley 24th Annual Global Healthcare Conference
- Goldman Sachs 47th Annual Global Healthcare Conference 2026
- Citi Annual Global Healthcare Conference 2025
- Special Call - Cabaletta Bio, Inc.
- Morgan Stanley 22nd Annual Global Healthcare Conference
- Special Call - Cabaletta Bio, Inc.
- J.P. Morgan 42nd Annual Healthcare Conference 2024
- Morgan Stanley 21st Annual Global Healthcare Conference 2023
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.